Advanced search
Publication Cover
Expert Opinion on Medical Diagnostics Volume 2, 2008 - Issue 12
Journal homepage
48
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Assessment of individual lung cancer risk by the proteomic analysis of exhaled breath condensate

I Eberini University of Milano, Department of Pharmacological Sciences, via Balzaretti 9-I-20133, Milano, Italy +39 02 5031 8311; +39 02 5031 8284; [email protected]
,
E Gianazza University of Milano, Department of Pharmacological Sciences, via Balzaretti 9-I-20133, Milano, Italy +39 02 5031 8311; +39 02 5031 8284; [email protected]
,
U Pastorino National Cancer Institute, Department of Thoracic Surgery, Milano, Italy
&
CR Sirtori University of Milano, Department of Pharmacological Sciences, via Balzaretti 9-I-20133, Milano, Italy +39 02 5031 8311; +39 02 5031 8284; [email protected]
Pages 1309-1315 | Published online: 19 Nov 2008

Bibliography

  • Kumar V, Cotran RS, Robbins SL. Basic pathology. 7th edition, Philadelphia: Saunders; 2003
  • Incidence of the major cancers, 2006, England at Office for National Statistics. Available from: http://www.statistics.gov.uk/cci/nugget [Last accessed: November 12, 2008]
  • Reed MF, Molloy M, Dalton EL, et al. Survival after resection for lung cancer is the outcome that matters. Am J Surg 2004;188(5):598-602
  • Cuzick J. Screening for cancer: Future potential. Eur J Cancer 1999;35(5):685-92
  • Bach PB, Jett JR, Pastorino U, et al. Computed tomography screening and lung cancer outcomes. JAMA 2007;297(9):953-61
  • Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355(17):1763-71
  • Black WC, Baron JA. CT screening for lung cancer: Spiraling into confusion? JAMA 2007;297:995-7
  • Granville CA, Dennis PA. An overview of lung cancer genomics and proteomics. Am J Respir Cell Mol Biol 2005;32(3):169-76
  • Alessandro R, Fontana S, Kohn E, et al. Proteomic strategies and their application in cancer research. Tumori 2005;91(6):447-55
  • Kikuchi T, Carbone DP. Proteomics analysis in lung cancer: challenges and opportunities. Respirology 2007;12:22-8
  • Conrad DH, Goyette J, Thomas PS. Proteomics as a method for early detection of cancer: A review of proteomics, exhaled breath condensate, and lung cancer screening. J Gen Intern Med 2008;23(Suppl 1):78-84
  • Buccheri G, Ferrigno D. Cytokeratin-derived markers of lung cancer. Expert Rev Mol Diagn 2001;1(3):315-22
  • Vejda S, Posovszky C, Zelzer S, et al. Plasma from cancer patients featuring a characteristic protein composition mediates protection against apoptosis. Mol Cell Proteomics 2002;1(5):387-93
  • Bharti A, Ma PC, Maulik G, et al. Haptoglobin α-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. Anticancer Res 2004;24(2C):1031-8
  • Maciel CM, Junqueira M, Paschoal ME, et al. Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients. J Exp Ther Oncol 2005;5(1):31-8
  • Heo SH, Lee SJ, Ryoo HM, et al. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics 2007;7(23):4292-302
  • Brichory F, Beer D, Le Naour F, et al. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res 2001;61(21):7908-12
  • He P, Naka T, Serada S, et al. Proteomics-based identification of α-enolase as a tumor antigen in non-small lung cancer. Cancer Sci 2007;98(8):1234-40
  • Yang F, Xiao ZQ, Zhang XZ, et al. Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. J Proteome Res 2007;6(2):751-8
  • Patz EF Jr, Campa MJ, Gottlin EB, et al. Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 2007;25(35):5578-83
  • Scheideler L, Manke HG, Schwulera U, et al. Detection of nonvolatile macromolecules in breath. A possible diagnostic tool? Am Rev Respir Dis 1993;148:778-84
  • Phillips M, Gleeson K, Hughes JM, et al. Volatile organic compounds in breath as markers of lung cancer: A cross-sectional study. Lancet 1999;353(9168):1930-3
  • Mutlu GM, Garey KW, Robbins RA, et al. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 2001;164(5):731-7
  • Horvath I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: Methodological recommendations and unresolved questions. Eur Respir J 2005;26(3):523-48
  • Rosias PP, Dompeling E, Hendriks HJ, et al. Exhaled breath condensate in children: Pearls and pitfalls. Pediatr Allergy Immunol 2004;15(1):4-19
  • Carpagnano GE, Foschino-Barbaro MP, Resta O, et al. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer. Oncology 2004;66(3):180-4
  • Carpagnano GE, Spanevello A, Curci C, et al. IL-2, TNF-α, and leptin: Local versus systemic concentrations in NSCLC patients. Oncol Res 2007;16(8):375-81
  • Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, et al. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J 2003;21(4):589-93
  • Gianazza E, Allegra L, Bucchioni E, et al. Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke. Am J Med 2004;117(1):51-4
  • Aoe K, Hiraki A, Murakami T, et al. Relative abundance and patterns of correlation among six cytokines in pleural fluid measured by cytometric bead array. Int J Mol Med 2003;12(2):193-8
  • Stathopoulos GT, Psallidas I, Moustaki A, et al. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion. J Natl Cancer Inst 2008;100(20):1464-76
  • Gharib TG, Chen G, Wang H, et al. Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia 2002;4(5):440-8
  • Malard V, Prat O, Darrouzet E, et al. Proteomic analysis of the response of human lung cells to uranium. Proteomics 2005;5(17):4568-80
  • Lau AT, Chiu JF. The possible role of cytokeratin 8 in cadmium-induced adaptation and carcinogenesis. Cancer Res 2007;67(5):2107-13
  • Debus E, Moll R, Franke WW, et al. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol 1984;114(1):121-30
  • Sundstrom BE, Stigbrand TI. Cytokeratins and tissue polypeptide antigen. Int J Biol Markers 1994;9(2):102-8
  • Broers JL, Ramaekers FC, Rot MK, et al. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. Cancer Res 1988;48(11):3221-9
  • Stieber P, Dienemann H, Hasholzner U, et al. Comparison of CYFRA 21-1, TPA and TPS in lung cancer, urinary bladder cancer and benign diseases. Int J Biol Markers 1994;9(2):82-8
  • Buccheri G. Tumor markers: clinical meaning and use. In: Lung Tumors. Brambilla C, Brambilla E, editors. Marcel Dekker: New York; 1999. p. 435-52
  • Weber K, Osborn M, Moll R, et al. Tissue polypeptide antigen (TPA) is related to the non-epidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: Re-evaluation of a human tumor marker. Embo J 1984;3(11):2707-14
  • Pujol JL, Cooper EH, Grenier J, et al. Clinical evaluation of serum tissue polypeptide-specific antigen (TPS) in non-small cell lung cancer. Eur J Cancer 1994;30A(12):1768-74
  • Griese M, Noss J, Von Bredow C. Protein pattern of exhaled breath condensate and saliva. Proteomics 2002;2:690-6
  • Gessner C, Dihazi H, Brettschneider S, et al. Presence of cytokeratins in exhaled breath condensate of mechanical ventilated patients. Respir Med 2008;102(2):299-306
  • Hoffmann HJ, Tabaksblat LM, Enghild JJ, et al. Human skin keratins are the major proteins in exhaled breath condensate. Eur Respir J 2008;31(2):380-4
  • Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003;362(9384):593-7
  • Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: Five-year prospective experience. Radiology 2005;235(1):259-65
  • Pastorino U. Early detection of lung cancer. Respiration 2006;73(1):5-13
  • Pastorino U. Does screening for stage I lung cancer improve survival in a high-risk population? Nat Clin Pract Oncol 2007;4(4):218-9
  • Midthun DE, Swensen SJ, Hartman TE, et al. Lung cancer screening results: Easily misunderstood. Mayo Clin Proc 2007;82(1):14-5
  • Greenberg AK, Lee MS. Biomarkers for lung cancer: Clinical uses. Curr Opin Pulm Med 2007;13(4):249-55
  • Yildiz PB, Shyr Y, Rahman JS, et al. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol 2007;2(10):893-901
  • D'amico TA. Molecular biologic staging of lung cancer. Ann Thorac Surg 2008;85(2):S737-42
  • Roxo-Rosa M, Da Costa G, Luider TM, et al. Proteomic analysis of nasal cells from cystic fibrosis patients and non-cystic fibrosis control individuals: Search for novel biomarkers of cystic fibrosis lung disease. Proteomics 2006;6(7):2314-25
  • Szturmowicz M. Cytokeratins – tissue and biochemical markers of non-small cell lung cancer. Pneumonol Alergol Pol 2007;75(4):315-6
  • Kosacka M, Jankowska R. The prognostic value of cytokeratin 19 expression in non-small cell lung cancer. Pneumonol Alergol Pol 2007;75(4):317-23
  • Ekman S, Eriksson P, Bergstrom S, et al. Clinical value of using serological cytokeratins as therapeutic markers in thoracic malignancies. Anticancer Res 2007;27(5B):3545-53
  • Kanaji N, Bandoh S, Fujita J, et al. Compensation of type I and type II cytokeratin pools in lung cancer. Lung Cancer 2007;55(3):295-302

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.